<DOC>
	<DOCNO>NCT00605137</DOCNO>
	<brief_summary>This trial conduct Japan . The aim trial investigate safety insulin detemir insulin NPH child type 1 diabetes .</brief_summary>
	<brief_title>Safety Insulin Detemir Children With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 1 diabetes least one year Current treatment basalbolus regimen least 12 week use intermediate/longacting human insulin insulin aspart and/or soluble human insulin HbA1C 11.0 % Willing comply Investigator 's instruction Able willing perform selfmonitoring capillary blood glucose take measure case hypoglycaemia Impaired renal function Impaired hepatic function Known hypoglycaemia unawareness recurrent major hypoglycaemia ( judged Investigator SubInvestigator ) Proliferative retinopathy maculopathy require acute treatment Uncontrolled treated/untreated hypertension Current treatment total daily insulin dose 2.00 IU/kg Current treatment expect screening start treatment systemic corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>